According to a meta-analysis that was published last week by Cochrane, marijuana may be able to reduce neuropathic pain, but not by a lot and not by much more than a placebo would.

The authors of the meta-analysis had evaluated 16 randomized, double-blind, placebo-controlled clinical trials. There were a total of 1,750 people that tested a variety of marijuana-derived compounds either against placebos or a pain killer.

20% of the people had cut their pain in half using cannabis while 17% of the people did the same with a placebo. 10% of the people withdrew from the trials due to the side effects.

Dr. Sachin Patel, a psychiatry professor and researcher at the Vanderbilt University Medical Center remarked to Newsweek, “There really is a lack of good, high-quality evidence about cannabis and cannabis products as they relate to therapeutic benefits in pain.”

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Massachusetts State House and Senate Reach Agreement on Retail Pot Tax
18 July 2017
Ohio Needs $11 Million For Its Medical Marijuana Program
24 July 2017
Aurora Cannabis and CannaRoyalty Sign LOI for International Drug Delivery Technology
14 December 2017